

| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $95K | -68.7% |
| SG&A Expense | $66K | -48.1% |
| Operating Income | -$4.3M | -17.3% |
| Interest Expense | $576K | +781.5% |
| Pre-tax Income | -$4.4M | -19.8% |
| Net Income | -$4.4M | -19.8% |
| EPS (Basic) | -$0.03 | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $10K | -45.0% |
| Current Assets | $42K | -73.7% |
| Total Assets | $1.4M | -23.8% |
| Current Liabilities | $596K | -20.0% |
| Total Liabilities | $1.3M | -55.4% |
| Stockholders' Equity | $86K | +107.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +25.9% |
| Capital Expenditures | $19K | +0.0% |
| Investing Cash Flow | -$238K | +46.2% |
| Financing Cash Flow | $1.2M | -38.6% |
| Free Cash Flow | -$1.2M | +25.6% |